Welcome to Academic Publishing House!

Experimental Approaches to Detect EBV Adaptive Immunity

$ 54.5

Pages:93
Published: 2026-08-05
ISBN:978-99993-5-087-7
Description Reviews (1) Leave review

Description

Epstein-Barr virus (EBV) has emerged as one of the most significant viral factors implicated in autoimmune and neurological diseases, particularly multiple sclerosis. This book provides a comprehensive overview of the cutting-edge immunological technologies used to investigate EBV-driven adaptive immune responses and their role in disease pathogenesis. Covering advanced methods such as immunofluorescence, MHC multimer technology, ELISpot, T-cell receptor sequencing, and PhIP-Seq, it combines theoretical foundations with detailed laboratory protocols and practical guidance. Drawing on the latest scientific evidence, the book demonstrates how these complementary approaches advance biomarker discovery, therapeutic development, and precision medicine. An essential resource for researchers, immunologists, virologists, neuroscientists, graduate students, and biomedical professionals working at the intersection of viral immunology and autoimmune disease.

Aug-21 2026

Review of Experimental Approaches to Detect EBV Adaptive Immunity
Experimental Approaches to Detect EBV AdaptiveImmunity providesatimely and valuable overview of experimental strategies forinvestigating adaptive immune responses to Epstein-Barr virus (EBV). The book addresses an
increasingly important area of research, given the strong association between EBV infection and a range of autoimmune, neurological, lymphoproliferative, and malignant diseases.
A major strength of the book is its methodological focus. It brings together contemporary approaches for detecting and characterizing EBV-specific B- and T-cell responses, including immunofluorescece-based assays, MHC multimer technologies, antigen-specific immune profiling, and related cellular and molecular techniques. By emphasizing experimental principles, applications, and interpretation, the book can help researchers select appropriate approaches for studying EBV-specific adaptive immunity in different disease settings



Get up to 50% Royalties

more info